ATRA
Companies
NASDAQ
Atara Biotherapeutics Inc.
Health Care
$8.02
-$5.29 (-39.74%)
Price Chart
Overview
About ATRA
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Market Cap
$63.7M
Volume
690.7K
Avg. Volume
484.1K
P/E Ratio
-0.7981756
Dividend Yield
0.00%
Employees
363.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.24
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ATRA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$63.7M
Volume690.7K
P/E Ratio-0.80
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 15, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025